Previous 10 | Next 10 |
2023-06-09 15:17:22 ET The US Food and Drug Administration is reportedly seeking temporary suppliers to help ease US shortages of methotrexate, a drug that is commonly used to treat cancer and autoimmune disorders such as rheumatoid arthritis. An FDA spokesperson told Reuters that the a...
2023-06-09 12:04:49 ET Teva Pharmaceutical Industries ( NYSE: TEVA ), Walgreens Boots Alliance ( NASDAQ: WBA ), CVS Health ( NYSE: CVS ) and AbbVie's ( NYSE: ABBV ) Allergan will pay $17.3B as part of a national settlement over their alleged roles in the US o...
2023-06-08 12:15:00 ET When patent protection expires on pharma companies' biggest sellers, it can be devastating for their finances. Due to the highly competitive nature of the pharmaceutical industry, it is no easy task to replace the aging stars in a drug portfolio. Teva Pharmaceut...
Settles with all 50 states and 99 percent of litigating subdivisions Shipments of life-saving generic Narcan ® (naloxone hydrochloride nasal spray) have already begun; payments to states to begin in the second half of 2023 Separate settlement reached with the final state ...
2023-06-07 09:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-06-07 07:00:00 ET Summary Markets overreacted to Norwich suing the FDA. Investors must consider recently reported weak Q1 results of Bausch Health. Reasons BHC stock is a buy from here. Last summer, Bausch Health ( BHC ) traded with wild 11% drops . Vola...
2023-06-06 08:07:09 ET Summary We put Vanda Pharmaceuticals in the spotlight today as this small biopharma concern just received Orphan Drug status on Friday for one of its pipeline assets. The company's franchise drug has had litigation setbacks. However, Vanda has other assets a...
Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers Phil Inc ., a patient access platform company that revolutionizes life science product commercialization, today announced an agreement with Teva Pharmaceut...
2023-06-05 10:00:00 ET On May 18, Teva Pharmaceuticals (NYSE: TEVA) announced that it was planning to execute a strategic pivot that would return the company to growth after a long period of stagnation. Between the upcoming fruits of its biosimilar generic medicines pipeline and its...
START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia (TD), including utilization and patient satisfaction AUSTEDO is the only vesicular monoamine transporter 2 (VMAT2) inhibitor with 3-year long-term data 1,2 ...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
Teva Pharmaceutical Industries Limited American Depositary Shares Website:
SPACE pediatric Phase 3 study met its primary end point for efficacy with a significantly greater reduction in Monthly Migraine Days compared to placebo Efficacy is consistent with AJOVY (fremanezumab) pivotal Phase 3 and Real-World Evidence studies in adults with no new emerg...
2024-07-10 08:00:08 ET Ashwani Verma from UBS issued a price target of $24.00 for TEVA on 2024-07-10 07:20:00. The adjusted price target was set to $24.00. At the time of the announcement, TEVA was trading at $15.81. The overall price target consensus is at $15.00 with h...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8...